2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Hematological Malignancy: new trials by email Literature Review of Hematological Malignancy trials Research Report on Hematological Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 BMS-986253 - Solid Tumor, Sars-CoV2 | Phase 2 | Terminated | Columbia University | 43 | 2020-04-16 | 2025-05-22 |
| Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL MT-3724 Phase 1, MT-3724 Phase 2 - Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 / Phase 2 | Terminated | Molecular Templates, Inc. | 38 | 2015-02-01 | 2022-08-18 |
Hematologic Neoplasms (2) · COVID-19 (1) · Coronavirus Infections (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms (1) · Recurrence (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms by Site (2) · Chronic Disease (1) · Coronaviridae Infections (1) · Disease Attributes (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1) · Leukemia, B-Cell (1) · Leukemia, Lymphoid (1) · Lung Diseases (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1)
HuMax-IL8 (1)
Columbia University (1) · Molecular Templates, Inc. (1)
United States (2) · Belarus (1) · Canada (1) · Georgia (1) · Israel (1) · Moldova (1) · Poland (1) · Serbia (1) · Spain (1) · Ukraine (1)
Mark N Stein, MD (1)